A major advance in cancer investigation is emerging with the use of nanobodies to reactivate mutated p53. This essential malignant suppressor protein is frequently disabled in various types of malignancies, leading https://icelisting.com/story23264701/vhh-fragments-revive-p53-a-potential-hope-for-malignant-management